Marketing

What do Novartis deal, PD-1 competition in China mean for tislelizumab? Here’s what BeiGene CEO has to say

MedicaloidJanuary 14, 2021

January 14, 2021

BeiGene has had a few busy weeks. In its home base of China, the company won national reimbursement for three products. Outside of China, it...

Alexion’s Ultomiris falls short in COVID-19 trial after months of testing in severe patients

MedicaloidJanuary 14, 2021January 14, 2021

January 14, 2021January 14, 2021

About a year after the initial COVID-19 outbreak, pharma companies have learned a lot about which drugs to focus on as potential treatments. And after testing in severe...

JPM: Sanofi’s new chief digital officer steps up ambitions in marketing, research and even e-commerce

MedicaloidJanuary 13, 2021

January 13, 2021

Sanofi CEO Paul Hudson came on the job touting his digital hopes for the company, and now he’s aiming to take the French drugmaker to...

Fierce JPM Week: Will AZ’s coronavirus vaccine turn a profit this year? It’s ‘too speculative’ to predict, exec says

MedicaloidJanuary 13, 2021January 13, 2021

January 13, 2021January 13, 2021

After AstraZeneca pledged not to profit off its COVID-19 shot during the pandemic, a report emerged that the drugmaker might be ready to declare the...

Fierce JPM Week: Moderna could join top vaccine players by sales this year, CEO says

MedicaloidJanuary 13, 2021

January 13, 2021

When J.P. Morgan hosted its healthcare conference last year, Moderna was a clinical-stage biotech company with promising technology and big ambitions. What a difference a...

JPM: Regeneron execs say ‘it’s a problem’ how few COVID-19 patients are getting antibody treatments

MedicaloidJanuary 12, 2021

January 12, 2021

To Regeneron, there’s no question about it: “We as a society have to do a much better job” of getting antibody therapies—such as the company’s...

Merck pulls close to Pfizer in next-gen pneumococcal vaccine race as FDA fast-tracks 15-strain vaccine

MedicaloidJanuary 12, 2021January 12, 2021

January 12, 2021January 12, 2021

Pfizer’s $5.8 billion-a-year Prevnar 13 is one of the company’s top blockbusters and the undisputed leader in the market for pneumococcal vaccines. But when it...

JPM: Gilead’s Veklury, now used in half of hospitalized U.S. COVID-19 patients, delivers multibillion-dollar revenue bump

MedicaloidJanuary 12, 2021

January 12, 2021

Gilead Sciences unveiled a surprise Monday: It enjoyed a bigger-than-expected sales boost from COVID-19 therapy Veklury, better known as remdesivir. But what changed since October,...

JPM: Alnylam CEO outlines aggressive plan to catapult into biotech’s top 5

MedicaloidJanuary 11, 2021

January 11, 2021

Alnylam CEO John Maraganore officially has a new-and-lofty goal: Vault the RNAi-focused company into the top five biotechs by market cap—by 2025. What’ll that take?...

Should pharma charity contributions be publicly disclosed, just like doctor payments? Senators say yes

MedicaloidJanuary 8, 2021January 8, 2021

January 8, 2021January 8, 2021

Pharma companies have inked a series of federal settlements over payments to charity organizations, which the federal government argues are a “conduit” to boosting drug...

What do Novartis deal, PD-1 competition in China mean for tislelizumab? Here’s what BeiGene CEO has to say

Alexion’s Ultomiris falls short in COVID-19 trial after months of testing in severe patients

JPM: Sanofi’s new chief digital officer steps up ambitions in marketing, research and even e-commerce

Fierce JPM Week: Will AZ’s coronavirus vaccine turn a profit this year? It’s ‘too speculative’ to predict, exec says

Fierce JPM Week: Moderna could join top vaccine players by sales this year, CEO says

JPM: Regeneron execs say ‘it’s a problem’ how few COVID-19 patients are getting antibody treatments

Merck pulls close to Pfizer in next-gen pneumococcal vaccine race as FDA fast-tracks 15-strain vaccine

JPM: Gilead’s Veklury, now used in half of hospitalized U.S. COVID-19 patients, delivers multibillion-dollar revenue bump

JPM: Alnylam CEO outlines aggressive plan to catapult into biotech’s top 5

Should pharma charity contributions be publicly disclosed, just like doctor payments? Senators say yes

3 Basic Moves for a Whole-body Kettlebell Workout...

To Build Emotional Strength, Expand Your Brain

Listen: Plasma and Immunity

Bengaluru: Aam Aadmi party clinic offers free treatment

Keto Egg Wrap with Collard Greens Recipe, 3...

Lonza to sell two plants to NextPharma as it plows ahead with $93M capsule expansion

Expert panel recommends permission for phase 1 clinical trial of Bharat Biotech’s nasal vaccine

Why Medical Tourism Is Drawing Patients, Even in a Pandemic

Vaccine hesitancy must end; nasal vaccine candidate could be a game-changer: Dr VK Paul – The Economic Times Video

The SAT is Dropping its Essay Section, Subject Matter Tests During Pandemic

The Best Shoes for Knee Arthritis May Be Stiff, Stable and Cushioned Ones

Once COVID-19 vaccine vial opened, it needs to be used fully within four hours: Senior doctors

Hillrom Gains Access to CAM Patch with Latest Acquisition

Egypt Denied an Oxygen Failure Killed Covid Patients. We Found That It Did.

AstraZeneca, Daiichi Sankyo push Enhertu closer to the blockbuster frontier with stomach cancer OK